NatCure Sciences, Inc.

Website http://www.natcure.com

Founded 2010

Employees 4

Follow

Overview

NatCure Sciences is a biopharmaceutical discovery company developing drug products isolated from plant extracts with history in traditional medicine from Africa and China. The lead product NAT-100 is being developed to treat Inflammatory Bowel Disease (IBD) and Multiple Sclerosis (MS). The active NAT-100 compound is water soluble with anti-inflammatory and immunosuppressive activity with little or no known-toxicity in man.

Management Team

Founder and CEO/CSO

Harout DerSimonian, PhD

Former assistant professor at Harvard Medical School and assistant immunologist at Massachusetts General Hospital. 20+ years of research and development experience in biotechnology with expertise in autoimmunity and transplantationdevelopment experience in biotechnology with expertise in autoimmunity and transplantation

VP, Drug Development and Quality Management

Abdellah Sentissi, PhD

Chemist, Pharmacist, and Biologist with 20+ years experience in creating and managing quality control laboratories and developing and implementing quality systems for biotechnology companies. Extensive experience in pharmaceutical Sciences with expertise in Quality Assurance and Drug Development

Director of Operations

Christopher Braudis Jr, MSc, RQAP-GLP

Experienced professional in GxP regulations, Quality Assurance, Regulatory Affairs, Auditing, Computer System Validation, Bioanalytical Method Validation, and Bioanalytical Sample Analysis